Project Grant HT94252411107
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $650,138 Project Grant to The Cleveland Clinic Foundation on September 1, 2024. The grant will fund a 2-year study focused on developing biomarkers to assess patient response to neurorestorative therapies for cervical spinal cord injuries. The Cleveland Clinic Foundation, a non-profit academic medical center, will leverage its expertise in neuroscience research to advance this...
The Cleveland Clinic Foundation was awarded a $712,508 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2025. The grant aims to assess the role of glycated apolipoprotein A1 (apoA1) in relation to cognitive complications of diabetes and preclinical Alzheimer's disease. As the primary awardee, Cleveland Clinic will analyze glycated apoA1 levels in plasma samples from...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The U.S. Defense Health Agency awarded a $1,917,278 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from July 1, 2025 to June 30, 2028, supports the organization's work on "Developing Neupron for Acute Spinal Cord Injury: Identifying Surrogate Biomarkers for Treatment Efficacy." The Cleveland Clinic Foundation, a prominent nonprofit academic medical center in...
The Cleveland Clinic Foundation will receive $942,000 under a three-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The funding will support research investigating the role of a novel inhibitory receptor complex in driving T cell dysfunction and therapeutic resistance to immunotherapies in lung cancer....
The Defense Health Agency awarded a $640,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation, a non-profit academic medical center, to conduct research focused on "Evolutionary Experimentation Highlights Novel Therapeutic Vulnerabilities in Endometrial Cancer." The award duration is from September 1, 2024 to August 31, 2026. The Cleveland Clinic Foundation, which has extensive experience as both a prime...
This Project Grant award of $471,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by The Cleveland Clinic Foundation to develop next-generation prostate cancer therapeutics by exploiting the allosteric regulation of the androgen receptor. The award period is from September 1, 2023 to August 31, 2025. As a prime recipient of federal grants, The Cleveland Clinic Foundation has a history of...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $999,999 Project Grant to The Cleveland Clinic Foundation to conduct research on "Inhibiting Demyelination Rescues Synapse Loss in Multiple Sclerosis." The grant period runs from June 1, 2024 to May 31, 2027. The Cleveland Clinic Foundation, a non-profit academic medical center, will use the funding to carry out innovative biomedical research aimed at developing new treatments...